FDA approves Dendreon cancer drug manufacturing facility in Atlanta
The manufacturing facility is the third location, besides New Jersey and Los Angeles facilities, at which Dendreon will produce Provenge (sipuleucel-T). The Atlanta facility includes 36 workstations, and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.